TAK-861 Shows Promise in Phase 2b Narcolepsy Type 1 Trial
TAK-861 demonstrated significant and sustained improvements in the treatment of narcolepsy type 1 in a phase 2b clinical trial.
Drug Administration Breakthrough Therapy Narcolepsy Type Wakefulness Test Epworth Sleepiness Scale Weekly Cataplexy Rate
Source: sleepreviewmag.com